Evolent Health

EOLS Micro Cap

Healthcare · Drug Manufacturers - Specialty & Generic

Aktualisiert: Apr 5, 2026, 17:43 UTC

$4.03

-6.5% heute

52W: $3.86 – $12.28

52W Low: $3.86 Position: 2% 52W High: $12.28

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

16.79x

Erwartetes KGV

P/S Ratio

0.88x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$262.2M

Marktkapitalisierung

Umsatzwachstum

14.4%

YoY Umsatzwachstum

Gewinnmarge

-17.38%

Nettomarge

ROE

—

Eigenkapitalrendite

Beta

Marktsensitivität

Short Interest

11.95%

% der Aktien leerverkauft

Ø Volumen

1,310,345

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Starker Kauf

6 Analysten

Ø Kursziel

$14.67

+263.94% Upside

Kursziel Spanne

$10.00 – $20.00

Über das Unternehmen

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Sektor: Healthcare Branche: Drug Manufacturers - Specialty & Generic Land: United States Mitarbeiter: 334 Börse: NGM

Trading-Daten

50-Day MA: $4.63

200-Day MA: $6.60

Volumen: 838,116

Ø Volumen: 1,310,345

Short Ratio: 5.23

Kurs/Buchwert: —

Verschuldung/EK: —

Free Cash Flow: $-26,697,750

Wo kann ich Evolent Health kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →